Table 1

Demographic and clinical characteristics

Aetiology

DPN

Fibromyalgia

s


Patients (n,%)

1623 (100.0%)

1434 (100.0%)

Male (n,%)

824 (50.8%)

153 (10.7%)

< 0.001

Female (n,%)

799 (49.2%)

1281 (89.3%)

Age (years) *

61.9 ± 13.0

51.9 ± 10.8

< 0.001

P25/P75

54/71

46/59

Height (cm) *

males

176.8 ± 7.5

176.5 ± 17.2

n.s.

females

164.2 ± 7.0

164.3 ± 8.0

n.s.

Weight (kg) *

males

90.8 ± 17.5

87.4 ± 20.9

n.s.

females

79.2 ± 16.2

74.5 ± 16.9

< 0.001

BMI (kg/m2) *

males

29.0 ± 5.1

27.9 ± 5.8

0.023

females

29.5 ± 6.2

27.6 ± 6.0

< 0.001


PHQ-9 score, depression

None (0-4)

27.9%

7.3%

< 0.001

Mild (5-9)

34.7%

27.0%

< 0.001

Moderate/moderately severe (10-19)

31.6%

51.6%

< 0.001

Severe (20-27)

5.8%

14.1%

< 0.001


Panic/anxiety disorder present

8.6%

17.9%

< 0.001


MOS sleep scale

Sleep disturbances [0;100] *

46.7 ± 24.6

53.4 ± 24.2

< 0.001

Optimal sleep

33.2%

31.2%

n.s.

Somnolence [0;100] *

46.5 ± 22.4

51.2 ± 21.5

< 0.001

Sleep quantity (hours) *

6.1 ± 1.6

5.9 ± 1.6

< 0.001

Sleep adequacy [0;100] *

49.6 ± 26.6

33.6 ± 25.4

< 0.001


*mean ± standard deviation

BMI: body mass index; P25/P75: 25% and 75% percentiles; DPN: painful diabetic neuropathy; n.s.: not significant.

Koroschetz et al. BMC Neurology 2011 11:55   doi:10.1186/1471-2377-11-55

Open Data